WOW! Instead of commending the company by keeping research

New Post Public Reply Private Reply Replies (0) Message Board
smarty72 Triple9 #8953
1,453
WOW! Instead of commending the company by keeping research costs low you are creating a negative that we are not multi-millions in debt to research a plant that we have so much knowledge already? Are you aware we have agreement with Sheba? Do you understand that Sheba is a world respected powerhouse in research and development and are footing much of the cost associated with the research? I am amazed so many do not realize how big of a deal teaming up with Sheba is for us and continue to think we are not spending enough.

The Sheba Medical Center, Israel's largest hospital has made a commitment to clinical excellence, based on a strong research and development foundation, by investing in professional human resources, infrastructure and facilities. Sheba provides its staff with a working environment that stimulates research and innovation of major medical needs for the benefit of patients. Sheba's excellence is highly acknowledged in Israel and around the globe.
Known for our groundbreaking medical research, the Sheba Medical Center (SMC) is home to major specialized research centers, integrating basic research, translational research and clinical studies across a broad spectrum of medical disciplines. Through our patient-focused approach and unique collaborative network across SMC institutes, local and global medical research centers, universities and medical industries, we have achieved solutions that improve patient care and save lives.
Our multidisciplinary research teams of clinical investigators, scientists, physicians and academia, strive to transform latest breakthroughs in science and technology into new cures, devices and diagnostic tools for the most challenging health conditions and diseases of the 21st century. We work together with top national and international biotech and medical companies and have an outstanding record of basic and clinical research and services, promoting effective translation from “bench to bedside". In addition, SMC is accredited by HHS regulation assurance of compliance for the protection of human subjects (Federal wide Assurance – FWA) making us eligible for US federal grants for research involving human clinical trials, thus serving as a major site for industry-sponsored clinical trials and clinical product development.
SMC research is funded by internal sources, donations, local and international research trusts, and private companies (biotech, pharmaceutical, medical device, etc.).
SMC Scientists and doctors, together with industry, co-develop breakthrough medical innovations, including therapeutic solutions, diagnostic tools, imaging modalities, drug delivery systems and medical devices.
Our internationally renowned scientists have made significant contributions to the advancement of knowledge and medical solutions in fields as diverse as cell biology, biotechnology, genetics, imaging, and medical technologies. Our mission is to continue to be a medical research powerhouse that will help to improve the lives of people in our region and around the globe.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

I AM ALS Celebrates Major Reauthorization Victory

Updated Category News Views 84

Historical Milestone in ALS Advocacy With the stroke of a pen, the ACT for ALS rose like a phoenix, securing much-needed stability for those locked in a relentless battle against this ravaging disease. But hey, it wasn't without sweat and elbow grease from a fiercely dedicated group. As the President signed this game-changer into law, I AM ALS and its army of advocates...

Continue Reading
Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 43

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
WeSalute's 'Heroes Meet Heroes' Unites Military, Athletes

Updated Category News Views 52

Every now and then, something stirs the soul in a way that neither Wall Street nor Main Street quite can. The 14th annual 'Heroes Meet Heroes' event by WeSalute is poised to do just that. Celebrating Service Through Shared Experiences WeSalute has been a cornerstone for veteran recognition for over two decades, fostering a sense of unity between military service members...

Continue Reading
Protalix to Reveal Q3 2026 Results Amid Rare Disease Push

Updated Category News Views 97

Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...

Continue Reading
Seaboard's Q3 Financials: A Mixed Bag for Investors

Updated Category News Views 103

Eyeing Seaboard's Earnings: What's the Deal? Seaboard Corporation just dropped its earnings report for the third quarter, and boy, it's a doozy. The numbers show a mixed bag—like finding out your favorite team won, but your best player got benched with an injury. On the surface, we've got a rise in net sales, but dig a little deeper, and the cracks start to show. Sales...

Continue Reading
Magnum Ice Cream Embraces Centric Software for PLM Boost

Updated Category News Views 20

Centric Software Steps Into the Ice Cream Game Revolutionizing the digital landscape of The Magnum Ice Cream Company (TMICC), Centric Software has been called to the plate to drive transformation in this global ice cream behemoth. With operations in over 80 countries and a portfolio as diverse as your neighborhood freezer section, TMICC's collaboration with Centric is set...

Continue Reading
Ian Marx Wins Pro Bono Honor at NJ Legal Awards

Updated Category News Views 81

A Champion in Legal Advocacy How often do we hear about a lawyer choosing the unglamorous path of pro bono work over the high-stakes allure of corporate law? Slam-dunk, you don’t. At the New Jersey Legal Awards, Ian S. Marx from Greenberg Traurig broke the mold, snagging the 'Pro Bono Lawyer of the Year' award. This isn’t just some pat on the back; it's recognition of...

Continue Reading
3M's Huge Settlement: Navigating A Looming Legal Fog

Updated Category News Views 94

The latest chapter in 3M’s legal saga reads like a courtroom drama, but this time, the company's shelling out big bucks to sidestep prolonged courtroom battles. They're committing to a $5.8 billion payout over several years, aiming to put a lid on a massive batch of PFAS-related lawsuits. It’s like they’re cleaning the spill with a velvet mop, but the trick is...

Continue Reading
Pentixapharm Advances PANDA Study, Hosts Earnings Call

Updated Category News Views 24

Pentixapharm Poised for PANDA Progress Picture a couple of ducks on a pond, calm on top but paddling like hell beneath the surface. That's Pentixapharm right now, charging ahead with their Phase 3 PANDA study while gearing up to spill the beans in an upcoming webcast. It's a biotech chess game, and these folks might just be positioning to yell 'checkmate' down the line....

Continue Reading
Surgical Planning Associates Expands HipInsight Options

Updated Category News Views 129

A Broader Horizon for Hip Surgery Planning Well, here we go—a medical technology play that's actually stirring things up, and not just blowing smoke. Surgical Planning Associates (SPA)—a name you might wanna keep an eye on—is turning heads with their HipInsight System. Just this week, they let it be known they've added five more implant systems to their 3D...

Continue Reading

Top 5 Most Recently Viewed Articles

Snap Inc. Faces Securities Class Action Lawsuit Claims

Updated Category News Views 212

Snap Inc. Faces Legal Challenges Over Securities Claims Snap Inc. finds itself amidst a legal storm as investors raise concerns regarding potential securities law violations. Recently, Levi & Korsinsky, LLP has taken on the significant task of representing investors affected by these alleged infractions. Understanding the Class Action Lawsuit This class action lawsuit is...

Continue Reading
Nightfood Holdings Inc. Leads AI Revolution in Hospitality Business

Updated Category News Views 179

Nightfood Holdings Inc. at the Vanguard of AI Technology As industries grapple with ongoing labor shortages and escalating consumer demands, companies are increasingly embracing the power of artificial intelligence (AI) to propel their operations forward. Nightfood Holdings Inc. is not just a participant but a leader in this transformative journey within the hospitality...

Continue Reading
DVIGear Unleashes Innovative DisplayNet AVoIP Solutions

Updated Category News Views 168

DVIGear Showcases Cutting-Edge Technology at InfoComm DVIGear, a prominent manufacturer in the digital connectivity sector, is gearing up to make a major impact at InfoComm 2025. From June 11-13, attendees at Booth 2221 will have the opportunity to engage with the company’s advanced signal distribution products. Highlighting the event will be the DisplayNet AVoIP...

Continue Reading
Discover the Growth Potential of Advanced Drainage Systems

Updated Category News Views 188

Understanding the Investment in Advanced Drainage Systems Advanced Drainage Systems (NYSE: WMS) has shown remarkable performance over the past decade, outstripping the overall market with a notable annualized return of 16.75%. This impressive figure translates to a substantial 4.29% increase compared to other market benchmarks. Investment Insights from Ten Years Ago...

Continue Reading
Understanding the Rising Short Interest in Targa Resources

Updated Category News Views 160

Exploring Targa Resources's Short Interest Trends Targa Resources's short interest, represented by the stock ticker TRGP, has seen a significant increase recently, rising by 4.66%. Currently, the company reports having 3.79 million shares sold short, which equates to approximately 2.02% of all its available shares for trading. This uptick in short positions suggests that...

Continue Reading